Is Burberry Group plc a top Footsie turnaround buy today?

G A Chester evaluates Burberry Group plc (LON:BRBY) and another FTSE 100 (INDEXFTSE: UKX) turnaround prospect.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Fashion house Burberry (LSE: BRBY) issued a trading update this morning and its shares are down 7.6% at 1,650p, as I’m writing. This is the second big one-day fall for the FTSE 100 firm in recent months, the shares having crashed 10% on 9 November from an all-time closing high of 1,985p the previous day.

Strategic vision

The November drop came on the back of half-year results and a strategy update from new chief executive Marco Gobbetti. Mr Gobbetti, whose background is in high-end fashion (he was boss of French label Céline from 2008 to 2016), detailed a multi-year plan to reposition Burberry as a super-luxury brand.

Today’s numbers for the three months to 31 December showed retail revenue falling 2% on a reported basis but increasing 1% at constant currency. The performance was not helped by a drop in the number of high-spending visitors to the UK. However, Mr Gobbetti said: “We are making good progress embedding our strategic vision into the organisation and remain on track to meet our full-year profit target.”

Great long-term value?

Burberry’s multi-year plan envisages “broadly stable” revenues and operating margins over the next two years, with cost-saving measures offsetting investment and “the rationalisation of non-luxury points of sale.” Analysts see this translating into modest annual advances in earnings per share (EPS), increasing from fiscal 2021 in line with management’s guidance of accelerating revenue growth and meaningful operating margin improvement.

Does Burberry offer good value for investors at the current share price? Shortly before the November price drop I rated the stock a ‘sell’, viewing the 12-month forward P/E of over 22 as simply too expensive. However, I suggested the shares “offer great long-term value when trading on a forward P/E in the teens.” Today, the P/E stands at 20. As such, Burberry is not yet back into my ‘buy’ territory but is a stock I’ll be keeping a close eye on.

Recovery room

Fellow FTSE 100 company Mediclinic International (LSE: MDC) has experienced a challenging couple of years and has seen its shares fall from a high of comfortably above 1,000p in summer 2016 to nearer 600p today. However, the private hospitals group, which operates in Southern Africa, Switzerland and the United Arab Emirates, is increasing revenues and has implemented cost-saving programmes and productivity initiatives.

Long-term demand for Mediclinic’s services, underpinned by ageing populations and a growing disease burden, bodes well for continuing top-line growth, while the measures taken on costs and productivity are set to deliver a strongly rising bottom line. The 12-month forward P/E is 19 and this falls near to 17 in the subsequent period, with analysts forecasting annual double-digit EPS growth for the foreseeable future.

Mediclinic’s P/E looks attractive to me in light of the outlook for earnings growth over the next few years and the structural story of rising long-term demand for the services the group offers. For these reasons, I rate the stock a ‘buy’.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended Burberry. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »